Finoriq research workspace
BeOne Medicines Ltd. (ONC) SEC Filings & Filing Highlights
Review SEC filings, SEC-derived company events, filing highlights, source excerpts, and material disclosure activity for BeOne Medicines Ltd. (ONC).
Company Snapshot
- Company
- BeOne Medicines Ltd. (ONC)
- Ticker
- ONC
- Market Cap
- $34.6B
- Latest Price
- $310.97
- Industry
- Biotech & Pharma
BeOne Medicines Ltd. (ONC) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BeOne Medicines Ltd. (ONC).
| Event | Form | Date |
|---|---|---|
| BEONE MEDICINES LTDAs previously disclosed in the Quarterly Report on Form 10-Q filed by BeOne Medicines Ltd. (the “Company”) with the Securities and Exchange... | 8-K8.01 | 2026-06-26 |
| BeOne Medicines Ltd.: Shareholder voteOn June 11, 2026, the Company held its Annual Meeting. As of May 22, 2026, the record date for the Annual Meeting (the “Record Date”), ther... | 8-K5.07 | 2026-06-11 |
| (b) As previously disclosed in the definitive proxy statement for the 2026 Annual General Meeti...(b) As previously disclosed in the definitive proxy statement for the 2026 Annual General Meeting of Shareholders (the “Annual Meeting”) of... | 8-K5.02 | 2026-06-11 |
| BeOne Medicines Ltd.: Corporate updateOn May 13, 2026, BeOne Medicines Ltd. announced that BEQALZI™ (sonrotoclax) has received accelerated approval from the U.S. Food and Drug A... | 8-K8.01 | 2026-05-15 |
| BeOne Medicines Announces First Quarter 2026 Financial Results and Business UpdatesBeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates | 8-K2.02 | 2026-05-06 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.